1. Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol 2006; 41: 513–23.
2. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466–79.
3. Ивашкин В.Т., Шептулин А.А., Лапина Т.Л. и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению функциональной диспепсии. РЖГГК. 2012; 3 (22): 80–92.
4. Маев И.В., Хавкин А.И., Вьючнова Е.С. и др. Функциональная (неязвенная) диспепсия: Учебно-методическое пособие. М.: ГОУ ВУНМЦ МЗ РФ, 2004.
5. Kaneko H, Mitsuma T, Uchida K et al. Immunoreactive-somatostatin, substance P, and calcitonin gene-related peptide concentrations of the human gastric mucosa in patients with nonulcer dyspepsia and peptic ulcer disease. Am J Gastroenterol 1993; 88 (6): 898–904.
6. Malagelada JR. Gastrointestinal motor disturbances in functional dyspepsia. Scand J Gastroenterol 1991; 26 (Suppl. 182): 29–32.
7. Mansi C, Borro P, Giacomini M et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000; 14: 561–9.
8. Fischler B, Tack J, De Gucht V et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003; 124: 903–10.
9. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med 2000; 134: 815–22.
10. Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatmentof functional dyspepsia. A meta-analysis of randomized controlledtrials. J Clin Gastroenterol 1989; 11: 169–77.
11. Moayyedi P. Dyspepsia. Curr Opin Gastroenterol 2012 Aug 22. E-publish ahead of print.
12. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239–55.
13. Arts J, Caenepeel P, Demedts I et al. Influence of erythromycin on gastric emptying and meal-related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005; 54: 455–60.
14. Delgado-Aros S, Camilleri M, Cremonini F et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127: 1685–94.
15. Kaess H, Kellermann M, Castro A. Food intolerance in duodenal ulcer patients, non ulcer dyspeptic patients and healthy subjects. A prospective study. Klin Wochenschr 1988; 66 (5): 208–11.
16. Tack J, Piessevaux H, Coulie B et al. Role of impaired gastric accommodation to a meal infunctional dyspepsia. Gastroenterology 1998; 115: 1346–52.
17. Mullan A, Kavanagh P, O'Mahony P et al. Food andnutrient intakes and eating patterns in functional and organic dyspepsia. Eur J Clin Nutr 1994; 48 (2): 97–105.
18. Filipovićć BF, Randjelovic T, Kovacevic N et al. Laboratory parameters and nutritional status in patients with functional dyspepsia. Eur J Intern Med 2011; 22 (3): 300–4.
19. Carvalho RVB, Lorena SLS, Almeida JZS, Mesquita MA. Food intolerance, diet composition, and eating patterns in functional dyspepsia. Dig Dis Sci 2010; 55: 60–5.
20. Sinn DH, Shin DH, Lim SW et al. The speed of eating and functional dyspepsia in young women. Gut Liver 2010; 4 (2): 173–8.
21. Tack J, Caenepeel P, Fischler B et al. Symptoms associatedwith hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121 (3): 526–35.
22. Gümürdülü Y, Serin E, Ozer B et al. The impact of B (12) treatment on gastric emptying time in patients with Helicobacter pylori infection. J Clin Gastroenterol 2003; 37: 230–3.
23. Boeckxstaens GE, Hirsch DP, Kuiken SD et al. The proximal stomach and postprandialsymptoms in functional dyspeptics. Am J Gastroenterol 2002; 97: 40–8.
24. Hasler WL. Dumping syndrome. Curr Treat Options Gastroenterol 2002; 5: 139–45.
25. Sarnelli G, Caenepeel P, Geypens B et al. Symptoms associated with impaired gastric emptying of solids andliquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783–8.
26. Cuomo R, Sarnelli G, Grasso R et al. Functional dyspepsia symptoms,gastric emptying and satiety provocative test: analysis of relationships. Scand J Gastroenterol 2001; 36: 1030–6.
27. Liau SS, Camilleri M, Kim DY et al. Pharmacological modulation of human gastric volumes demonstratednoninvasively using SPECT imaging. Neurogastroenterol Motil 2001; 13: 533–42.
28. Tack J, Broeckaert D, Coulie B, Janssens J. The influence ofcisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther 1998; 12: 761–6.
29. Tack J, Vos R, Janssens J et al. Influence of tegaserod on proximal gastric tone and on the perceptionof gastric distension. Aliment Pharmacol Ther 2003; 18: 1031–7.
30. Zhang X, Tack J, Janssens J, Sifrim DA. Effect of sildenafil, aphosphodiesterase-5 inhibitor, on oesophageal peristalsis andlower oesophageal sphincter function in cats. Neurogastroenterol Motil 2001; 13: 325–31.
31. Lee JI, Park H, Kim JH et al. The effect of sildenafilon oesophageal motor function in healthy subjects and patientswith nutcracker oesophagus. Neurogastroenterol Motil 2003; 15: 617–23.
32. Диетология: Руководство. 2-е изд. Под ред. А.Ю.Барановского. СПб.: Питер, 2006.
33. Cheng CP, Tsai SW, Chiu CP et al. The effect of probiotic-fermented soy milk on enhancing the NO-mediated vascular relaxation factors. J Sci Food Agric 2012 Aug 21. doi: 10.1002/jsfa.5880. [Epub ahead of print]
34. Feinle-Bisset C, Horowitz M. Dietary factors in functional dyspepsia. Neurogastroenterol Motil 2006; 18: 608–18.
35. Friedlander P. Food and indigestion. BMJ 1959; 2: 1454–8.
36. Cuperus P, Keeling PW, Gibney MJ. Eating patterns in functional dyspepsia: a case control study. Eur J Clin Nutr 1996; 50: 520–3.
37. Saito YA, Locke GR III, Weaver AL et al. Diet and functional gastrointestinal disorders: apopulation-based case–control study. Am J Gastroenterol 2005; 100: 2743–8.
38. Sugerman H, Windsor A, Bessos M, Wolfe L. Intra-abdominal pressure, sagittalabdominal diameter and obesity comorbidity. J Intern Med 1997; 241: 71–9.
39. Houghton LA, Mangnall YF, Dwivedi A, Read NW. Sensitivityto nutrients in patients with non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 1993; 5: 109–13.
40. Feinle-Bisset C, Meier B, Fried M, Beglinger C. Role of cognitive factors insymptom induction following high and low fat meals in patients with functionaldyspepsia. Gut 2003; 52 (10): 1414–8.
41. Barbera R, Feinle C, Read NW. Nutrient-specific modulationof gastric mechanosensitivity in patients with functionaldyspepsia. Dig Dis Sci 1995; 40: 1636–41.
42. Feinle C, Meier O, Otto B et al. Role ofduodenal lipid and cholecystokinin A receptors in thepathophysiology of functional dyspepsia. Gut 2001; 48: 347–55.
43. Pilichiewicz A, Feltrin KL, Horowitz M et al. Oral carbohydrate andfat differentially modulate symptoms, gut hormones and antralarea in functional dyspepsia. Am J Gastroenterol 2008; 103: 2613–23.
44. Kearney J, Kennedy NP, Keeling PW et al. Dietary intakes and adipose tissue levels of linoleic acid in peptic ulcer disease. Br J Nutr 1989; 62: 699–706.
45. Bijkerk CJ, Muris JW, Knottnerus JA et al. Systematic review: the role of different types of fibre in the treatmentof irritable bowel syndrome. Aliment Pharmacol Ther 2004; 19: 245–51.
46. Ramulu P, Rao PU. Effect of processing on dietary fiber content of cereals and pulses. Plant Foods Hum Nutr 1997; 50: 249–57.
47. Harju E. Guar gum benefits duodenal ulcer patients by decreasing gastric acidity and rate of emptying of gastric contents 60 to 120 minutes postprandially. Am Surg 1984; 50: 668–72.
48. Gonlachanvit S. Are Rice and Spicy Diet Good for FunctionalGastrointestinal Disorders? J Neurogastroenterol Motil 2010; 16: 131–8.
49. Giannini EG, Mansi C, Dulbecco P, Savarino V. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition 2006; 22: 334–42.
50. Prior A, Whorwell PJ. Double blind study of ispaghula in irritable bowel syndrome. Gut 1987; 28: 1510–3.
51. Ryan-Harshman M, Aldoori W. How diet and lifestyle affect duodenal ulcers. Review of the evidence. Can Fam Physician 2004; 50: 727–32.
52. Anderson JW, Baird P, Davis RH et al. Health benefits of dietary fiber. Nutrition Reviews 2009; 67 (4): 188–205.
53. Gonlachanvit S, Mahayosnond A, Kullavanijaya P. Effects of chili onpostprandial gastrointestinal symptoms in diarrhoea predominant irritablebowel syndrome: evidence for capsaicin-sensitive visceral nociceptionhypersensitivity. Neurogastroenterol Motil 2009; 21: 23–32.
54. Hammer J, Fuhrer M, Pipal L, Matiasek J. Hypersensitivity forcapsaicin in patients with functional dyspepsia. Neurogastroenterol Motil 2008; 20: 125–33.

С.В.Морозов

ФГБУ НИИ питания РАМН, Москва